Uniquely expressing diverse innate-like and adaptive-like functions, γδ T cells exist as specialized subsets, but are also able to adapt in response to environmental cues. These cells have long been known to rapidly proliferate following primary malaria infection in humans and mice, but exciting new work is shedding light into their diverse functions in protection and following repeated malaria infection. In this review, we examine the current knowledge of functional specialization of γδ T cells in malaria, and the mechanisms dictating recognition of malaria parasites and resulting proliferation. We discuss γδ T cell plasticity, including changing interactions with other immune cells during recurrent infection and potential for immunologica...
Malaria is a vector-borne infectious disease caused by unicellular parasites of the genus Plasmodium...
Repeated Plasmodium falciparum infections drive the development of clinical immunity to malaria in h...
Plasmodium falciparum malaria causes 500 million clinical cases with approximately one million death...
Naturally acquired protective immunity to Plasmodium falciparum malaria is mainly antibody-mediated....
International audienceMalaria is an infectious disease caused by the protozoan parasite Plasmodium s...
Objective: CD4+ T cells are critical mediators of immunity to Plasmodium spp. infection, but their c...
Malaria is an old scourge of humankind and has a large negative impact on the economic development o...
Protective immunity generated following malaria infection may be comprised of Ab or T cells against ...
Plasmodium spp., the causative agent of malaria, caused 212 million infections in 2016 with 445,000 ...
Malaria is caused by apicomplexan parasites of the genus Plasmodium. While infection continues to po...
The inability to acquire protective immunity against Plasmodia is the chief obstacle to malaria cont...
CD4 T cells orchestrate immunity against blood-stage malaria. However, a major challenge in designin...
Although clinical immunity to malaria eventually develops among children living in endemic settings,...
Protective immunity generated following malaria infection may be comprised of Ab or T cells against ...
Malaria remains a serious threat to global health. Sustained malaria control and, eventually, eradic...
Malaria is a vector-borne infectious disease caused by unicellular parasites of the genus Plasmodium...
Repeated Plasmodium falciparum infections drive the development of clinical immunity to malaria in h...
Plasmodium falciparum malaria causes 500 million clinical cases with approximately one million death...
Naturally acquired protective immunity to Plasmodium falciparum malaria is mainly antibody-mediated....
International audienceMalaria is an infectious disease caused by the protozoan parasite Plasmodium s...
Objective: CD4+ T cells are critical mediators of immunity to Plasmodium spp. infection, but their c...
Malaria is an old scourge of humankind and has a large negative impact on the economic development o...
Protective immunity generated following malaria infection may be comprised of Ab or T cells against ...
Plasmodium spp., the causative agent of malaria, caused 212 million infections in 2016 with 445,000 ...
Malaria is caused by apicomplexan parasites of the genus Plasmodium. While infection continues to po...
The inability to acquire protective immunity against Plasmodia is the chief obstacle to malaria cont...
CD4 T cells orchestrate immunity against blood-stage malaria. However, a major challenge in designin...
Although clinical immunity to malaria eventually develops among children living in endemic settings,...
Protective immunity generated following malaria infection may be comprised of Ab or T cells against ...
Malaria remains a serious threat to global health. Sustained malaria control and, eventually, eradic...
Malaria is a vector-borne infectious disease caused by unicellular parasites of the genus Plasmodium...
Repeated Plasmodium falciparum infections drive the development of clinical immunity to malaria in h...
Plasmodium falciparum malaria causes 500 million clinical cases with approximately one million death...